Results 151 to 160 of about 2,553,881 (244)

The Bidirectional Association Between MASLD and Male Hypogonadism: An Updated Meta‐Analysis

open access: yesAndrology, EarlyView.
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) and male hypogonadism are increasingly prevalent, metabolically interrelated conditions. Testosterone (T) deficiency has been implicated in hepatic lipid dysregulation, insulin resistance, and visceral adiposity, whereas MASLD may impair the hypothalamic–pituitary ...
Giorgia Spaggiari   +9 more
wiley   +1 more source

Thyroid hormone receptor beta mutations alter photoreceptor development and function in Danio rerio (zebrafish). [PDF]

open access: yesPLoS Genet, 2020
Deveau C   +7 more
europepmc   +1 more source

Hypogonadism in Cisgender Men Living With HIV: Prevalence, Clinical and Metabolic Features

open access: yesAndrology, EarlyView.
ABSTRACT Background Hypogonadism is frequently observed in men living with human immunodeficiency virus (HIV), although its prevalence, etiology, and predictors remain incompletely understood. Objective To evaluate the prevalence of hypogonadism and its association with metabolic factors in men living with HIV (MLWH), on stable antiretroviral therapy ...
Felipe Augusto Azevedo Leao   +8 more
wiley   +1 more source

TSHR (thyroid stimulating hormone receptor).

open access: yes, 2009
TSHR (Thyroid Stimulating Hormone Receptor) gene DNA: position, structure, transcription Protein: structure, expression, localization, function Mutations: somatic and germinal mutations Disease/oncogenesis: Thyroid adenoma, Toxic multinodular goiter (
IOSCO, CARMELA, RHODEN, KERRY JANE
core  

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

Home - About - Disclaimer - Privacy